SLDB

NASDAQ · Biotechnology

Solid Biosciences Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.26

+0.58 (+8.68%)

As of Mar 25, 2:50 PM ET ·

Financial Highlights (FY 2025)

Revenue

294.33M

Net Income

32.12M

Gross Margin

54.9%

Profit Margin

10.9%

Rev Growth

+16.9%

D/E Ratio

0.34

Revenue & Net Income

Margin Trends

	FY 2025	FY 2024	FY 2023
Gross Margin	54.9%	54.9%	54.9%
Operating Margin	11.6%	10.9%	11.9%
Profit Margin	10.9%	12.5%	10.1%

Income Statement

	FY 2025	FY 2024	FY 2023
Revenue	294.33M	265.12M	296.42M
Gross Profit	161.65M	145.61M	162.80M
Operating Income	34.19M	29.02M	35.25M
Net Income	32.12M	33.11M	29.81M
Gross Margin	54.9%	54.9%	54.9%
Operating Margin	11.6%	10.9%	11.9%
Profit Margin	10.9%	12.5%	10.1%
Rev Growth	+16.9%	-8.0%	-9.5%

Balance Sheet

	FY 2025	FY 2024	FY 2023
Total Debt	84.11M	71.30M	90.12M
Total Equity	250.64M	261.66M	250.70M
D/E Ratio	0.34	0.27	0.36

Cash Flow

	FY 2025	FY 2024	FY 2023
EBITDA	56.98M	46.74M	49.34M
Free Cash Flow	40.15M	38.44M	35.75M